about
A synthesis of best evidence for the restoration of upper-extremity function in people with tetraplegiaNonoperative management of cervical myelopathy: a systematic review.Is surgery for cervical spondylotic myelopathy cost-effective? A cost-utility analysis based on data from the AOSpine North America prospective CSM study.Outcome of the upper limb in cervical spinal cord injury: Profiles of recovery and insights for clinical studiesGlobal prevalence and incidence of traumatic spinal cord injury.Clinically Feasible Microstructural MRI to Quantify Cervical Spinal Cord Tissue Injury Using DTI, MT, and T2*-Weighted Imaging: Assessment of Normative Data and Reliability.Outcome Measures for Acute/Subacute Cervical Sensorimotor Complete (AIS-A) Spinal Cord Injury During a Phase 2 Clinical Trial.Cervical spondylotic myelopathy: the clinical phenomenon and the current pathobiology of an increasingly prevalent and devastating disorder.Neurological grading in traumatic spinal cord injury.Ancillary outcome measures for assessment of individuals with cervical spondylotic myelopathy.Views of individuals with spinal cord injury on the use of wearable cameras to monitor upper limb function in the home and community.181 Guidelines for the Management of Patients With Spinal Cord Injury: The Optimal Timing of Decompression.Diagnosis, heritability, and outcome assessment in cervical myelopathy: a consensus statement.Spinal cord stimulation in primary progressive freezing of gait.Predicting task performance from upper extremity impairment measures after cervical spinal cord injury.Changes in Strength, Sensation, and Prehension in Acute Cervical Spinal Cord Injury: European Multicenter Responsiveness Study of the GRASSP.Preoperative magnetic resonance imaging is associated with baseline neurological status and can predict postoperative recovery in patients with cervical spondylotic myelopathy.A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on the Type and Timing of Rehabilitation.A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on the Type and Timing of Anticoagulant Thromboprophylaxis.Do quantitative magnetic resonance imaging parameters correlate with the clinical presentation and functional outcomes after surgery in cervical spondylotic myelopathy? A prospective multicenter study.Clinical prediction model for acute inpatient complications after traumatic cervical spinal cord injury: a subanalysis from the Surgical Timing in Acute Spinal Cord Injury Study.A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on the Use of Methylprednisolone Sodium Succinate.Psychometric properties of the modified Japanese Orthopaedic Association scale in patients with cervical spondylotic myelopathy.A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury and Central Cord Syndrome: Recommendations on the Timing (≤24 Hours Versus >24 Hours) of Decompressive Surgery.A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on the Role of Baseline Magnetic Resonance Imaging in Clinical Decision Making and Outcome Prediction.A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression.Type and Timing of Rehabilitation Following Acute and Subacute Spinal Cord Injury: A Systematic Review.The Graded and Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) Version 2 provides interval measure properties.Abstracts and Workshops 7th National Spinal Cord Injury Conference November 9 - 11, 2017 Fallsview Casino Resort Niagara Falls, Ontario, Canada.Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trials.A Novel MRI Biomarker of Spinal Cord White Matter Injury: T2*-Weighted White Matter to Gray Matter Signal Intensity Ratio.Development of the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP): reviewing measurement specific to the upper limb in tetraplegia.The Graded Redefined Assessment of Strength Sensibility and Prehension: reliability and validity.Responsiveness, Sensitivity, and Minimally Detectable Difference of the Graded and Redefined Assessment of Strength, Sensibility, and Prehension, Version 1.0.Defining the role of sensation, strength, and prehension for upper limb function in cervical spinal cord injury.Monitoring for myelopathic progression with multiparametric quantitative MRI.163 Microstructural MRI Quantifies Tract-Specific Injury and Correlates With Global Disability and Focal Neurological Deficits in Degenerative Cervical MyelopathyPostoperative Magnetic Resonance Imaging Can Predict Neurological Recovery After Surgery for Cervical Spondylotic Myelopathy: A Prospective Study With Blinded AssessmentsFunctional and clinical outcomes following surgical treatment in patients with cervical spondylotic myelopathy: a prospective study of 81 casesCorrection: Monitoring for myelopathic progression with multiparametric quantitative MRI
P50
Q26861445-E103BB43-9229-4A59-B284-A8C42C1C341BQ30456896-14B01529-F65A-46B3-A880-D6A85CF6EC54Q30566748-EF920E71-D56A-4F25-ACD7-AC1778407DCCQ34197849-2948D6DB-5849-4111-9C99-C7255877A793Q34265912-DB3CA6A1-9951-4480-8D87-0342A14FACCDQ36352821-C2CC2756-B122-403C-9506-56EB84E95C13Q36458688-C57E5859-72C7-4ED9-BCAE-F2C024E2D4ABQ38064395-EAA00694-8974-40E4-B086-2EF45EC439F4Q38072523-38FE9732-6FED-4ED2-84DF-857C28CCB3A8Q38130418-4EE71A9F-7129-42EE-BCA9-B88F1C3F9627Q38664382-53DB5537-F759-4A6B-9A7C-A57CD3675BBBQ38892284-4763AF3C-9646-468A-B418-3A460BEDFDF9Q39364014-2F910E6B-EC5D-4514-BA27-1BCE432F8772Q39417840-EE23AC5F-4513-46A3-8175-58FCDD28A72CQ39724770-6C58CA88-F063-4FB1-9928-72A310887D2BQ41612162-F4E73446-5224-469D-9191-1CE435A7300DQ43601360-F1C6A1B8-37E8-4DD6-AF2F-FCD16D131FEDQ44072436-629ED9B5-C2C9-4D17-88F6-BF38228FA89BQ44487984-203FBE49-BEAF-4FE2-BE40-A064F30D019EQ44737981-F8F0F718-2EA2-43D6-8323-ECDB27455D83Q45235530-5B1A1F1A-D26D-4E9D-ACEF-722336746712Q45762549-C0657D3B-7FB7-4137-9366-ACE92645B367Q46013589-CD6E4DFD-7182-4762-BFDD-E749787828E8Q46889091-8D7B001E-7135-47BB-98C9-45176E3CA1D6Q47095658-08889777-1239-48FC-B31A-32A382870938Q47154187-95EEBA17-3557-47D3-88A2-78931322823AQ47162601-E1815A3F-CC59-4A49-9C56-2DC32A16BC3DQ47328190-A5444738-1AE7-46A8-865F-265C910D1CE6Q47442293-6D3286F9-FED1-4706-B1CB-A9554FBF5840Q47667273-26FFE838-B633-46CB-BF60-CE7E9B75DCFFQ48251746-A6EAEA80-769D-4E84-A664-6B7D8A3EE8A7Q48610708-2B02DF53-D438-42C6-A8D5-1D52B2667C8CQ48871902-F88C3C9C-F065-4EE9-8A4C-5033E82AC322Q48919777-D9D5A0C6-9AF9-4688-A3CE-903476BD8BCDQ51198762-01A96CB8-5096-4E6A-9560-0B5247A99482Q55400359-C4B6A70D-05E0-4B85-B09D-BAE5E938599DQ57372078-59B09A62-F440-4133-B5C9-7DC970523EDCQ57839316-76C86E82-9260-41FF-A8BE-653E20F888BBQ57839329-B6BC99C5-8292-451B-A218-388E085F38BEQ58747766-060189D2-454A-40E6-9DA0-569FB729216A
P50
description
researcher ORCID ID = 0000-0003-2332-5986
@en
name
Sukhvinder Kalsi-Ryan
@ast
Sukhvinder Kalsi-Ryan
@en
Sukhvinder Kalsi-Ryan
@es
Sukhvinder Kalsi-Ryan
@nl
type
label
Sukhvinder Kalsi-Ryan
@ast
Sukhvinder Kalsi-Ryan
@en
Sukhvinder Kalsi-Ryan
@es
Sukhvinder Kalsi-Ryan
@nl
prefLabel
Sukhvinder Kalsi-Ryan
@ast
Sukhvinder Kalsi-Ryan
@en
Sukhvinder Kalsi-Ryan
@es
Sukhvinder Kalsi-Ryan
@nl
P1153
6505471337
P31
P496
0000-0003-2332-5986